CMCSA
49
3
VIX
41
-11
JCI
44
7
NI
63
5
DOV
48
2
APH
53
3
WFC
58
8
F
38
4
HCA
37
7
CME
59
3
ROK
46
3
MSFT
55
2
OXY
42
17
MS
64
3
TROW
37
8
HBAN
47
7
PEP
33
4
AON
25
4
TSCO
42
4
HCP
54
2
CMCSA
49
3
VIX
41
-11
JCI
44
7
NI
63
5
DOV
48
2
APH
53
3
WFC
58
8
F
38
4
HCA
37
7
CME
59
3
ROK
46
3
MSFT
55
2
OXY
42
17
MS
64
3
TROW
37
8
HBAN
47
7
PEP
33
4
AON
25
4
TSCO
42
4
HCP
54
2
Financhill
Back

Immatics NV 10K Form

Sell
32

IMTX
Immatics NV

Last Price:
$6.87
Seasonality Move:
0.83%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive IMTX News And Ratings

See the #1 stock for the next 7 days that we like better than IMTX

IMTX Financial Statistics

Sales & Book Value

Annual Sales: $58.5M
Cash Flow: $-42M
Price / Cash Flow: 0
Annual Sales: $4.14
Price / Book: 1.95

Profitability

EPS (TTM): -0.67050
Net Income (TTM): $-60.3M
Gross Margin: --
Return on Equity: -16.88%
Return on Assets: -9.89%

Immatics NV Earnings Forecast

Key Immatics NV Financial Ratios

  • The Research & Development expenses have been 219.76% of Revenue.
  • The Interest Expense is -0.86% of Operating Income.
  • The Net Earning history of IMTX is -179.63% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

Immatics NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: IMTX
Website: immatics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.98
Quick Ratio: 3.87

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IMTX Technical Analysis vs Fundamental Analysis

Sell
32
Immatics NV (IMTX) is a Sell

Is Immatics NV a Buy or a Sell?

  • Immatics NV stock is rated a Sell
    The current Immatics NV [IMTX] share price is $6.85. The Score for IMTX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.